ReviewAnnals of medicine2026
Diabetic cerebral microvascular disorder: from key pathologies to targeted interventions.
Review in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes mellitus, a highly prevalent metabolic disorder worldwide, poses a severe threat to patient health primarily through its debilitating vascular complications. The cerebral microvasculature, essential for maintaining brain homeostasis and function, is particularly vulnerable to diabetic injury. However, diabetic cerebral microvascular disorder-a key contributor of neurological diseases like stroke, dementia, and cerebral small vessel disease-remains insufficiently characterized, and its pathophysiological mechanisms and therapeutic implications are not yet fully integrated.
findingsThis review comprehensively summarizes the structural and functional abnormalities of cerebral microcirculation in diabetes, encompassing pathological neovascularization, pathological remodeling, blood-brain barrier disruption, cerebrovascular reactivity impairment, capillary stalling, impaired autoregulation, and neurovascular uncoupling. These microvascular alterations are then examined in relation to major neurological diseases, such as stroke, cerebral small vessel disease, cognitive impairment, Parkinson's disease, and depression. Current and emerging interventions, ranging from lifestyle modification and glucose-lowering therapies to mechanism-targeted strategies, are also discussed. While this review covers cerebral microvascular alterations across diabetes subtypes, it should be noted that the majority of currently available evidence derives from studies in type 2 diabetes.
conclusionsThis review provides a comprehensive synthesis of current knowledge on diabetic cerebral microvascular disorder, providing a framework for mechanistic research and supporting the clinical translation of microcirculation-targeted strategies for managing diabetes-related neurological complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.